Insufficient scRNA-seq data for expression of IL3 at single-cell level.
Insufficient scRNA-seq data for expression of IL3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 54% | 1.33 | 121 / 226 | 0% | 0.00 | 1 / 406 |
lung | 25% | 0.45 | 144 / 578 | 0% | 0.01 | 4 / 1155 |
blood vessel | 25% | 0.43 | 332 / 1335 | 0% | 0 | 0 / 0 |
spleen | 19% | 0.49 | 46 / 241 | 0% | 0 | 0 / 0 |
breast | 14% | 0.19 | 65 / 459 | 0% | 0.00 | 1 / 1118 |
stomach | 12% | 0.17 | 44 / 359 | 0% | 0.00 | 1 / 286 |
esophagus | 12% | 0.18 | 178 / 1445 | 0% | 0 | 0 / 183 |
intestine | 11% | 0.17 | 107 / 966 | 0% | 0 | 0 / 527 |
brain | 11% | 0.18 | 283 / 2642 | 0% | 0 | 0 / 705 |
uterus | 11% | 0.16 | 18 / 170 | 0% | 0 | 0 / 459 |
prostate | 10% | 0.18 | 25 / 245 | 0% | 0 | 0 / 502 |
thymus | 10% | 0.14 | 65 / 653 | 0% | 0.00 | 1 / 605 |
bladder | 10% | 0.14 | 2 / 21 | 0% | 0 | 0 / 504 |
kidney | 9% | 0.13 | 8 / 89 | 0% | 0 | 0 / 901 |
muscle | 8% | 0.11 | 68 / 803 | 0% | 0 | 0 / 0 |
skin | 8% | 0.11 | 147 / 1809 | 0% | 0 | 0 / 472 |
peripheral blood | 8% | 0.13 | 74 / 929 | 0% | 0 | 0 / 0 |
heart | 7% | 0.10 | 62 / 861 | 0% | 0 | 0 / 0 |
adipose | 7% | 0.11 | 82 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 6% | 0.07 | 15 / 258 | 0% | 0.01 | 1 / 230 |
pancreas | 5% | 0.07 | 18 / 328 | 0% | 0 | 0 / 178 |
ovary | 4% | 0.07 | 8 / 180 | 0% | 0 | 0 / 430 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0006955 | Biological process | immune response |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0038156 | Biological process | interleukin-3-mediated signaling pathway |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0007399 | Biological process | nervous system development |
GO_0007267 | Biological process | cell-cell signaling |
GO_0035162 | Biological process | embryonic hemopoiesis |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005135 | Molecular function | interleukin-3 receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005125 | Molecular function | cytokine activity |
GO_0008083 | Molecular function | growth factor activity |
Gene name | IL3 |
Protein name | Interleukin-3 (IL-3) (Hematopoietic growth factor) (Mast cell growth factor) (Multipotential colony-stimulating factor) (P-cell-stimulating factor) Interleukin-3 (IL-3) (Hematopoietic growth factor) (Mast cell growth factor) (MCGF) (Multipotential colony-stimulating factor) (P-cell-stimulating factor) |
Synonyms | |
Description | FUNCTION: Cytokine secreted predominantly by activated T-lymphocytes as well as mast cells and osteoblastic cells that controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells . Stimulates also mature basophils, eosinophils, and monocytes to become functionally activated . In addition, plays an important role in neural cell proliferation and survival . Participates as well in bone homeostasis and inhibits osteoclast differentiation by preventing NF-kappa-B nuclear translocation and activation . Mechanistically, exerts its biological effects through a receptor composed of IL3RA subunit and a signal transducing subunit IL3RB . Receptor stimulation results in the rapid activation of JAK2 kinase activity leading to STAT5-mediated transcriptional program (By similarity). Alternatively, contributes to cell survival under oxidative stress in non-hematopoietic systems by activating pathways mediated by PI3K/AKT and ERK . . FUNCTION: Cytokine secreted predominantly by activated T-lymphocytes as well as mast cells and osteoblastic cells that controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells. Stimulates also mature basophils, eosinophils, and monocytes to become functionally activated. In addition, plays an important role in neural cell proliferation and survival. Participates as well in bone homeostasis and inhibits osteoclast differentiation by preventing NF-kappa-B nuclear translocation and activation. Mechanistically, exerts its biological effects through a receptor composed of IL3RA subunit and a signal transducing subunit IL3RB. Receptor stimulation results in the rapid activation of JAK2 kinase activity leading to STAT5-mediated transcriptional program. Alternatively, contributes to cell survival under oxidative stress in non-hematopoietic systems by activating pathways mediated by PI3K/AKT and ERK. . FUNCTION: Cytokine secreted predominantly by activated T-lymphocytes as well as mast cells and osteoblastic cells that controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells. Stimulates also mature basophils, eosinophils, and monocytes to become functionally activated. In addition, plays an important role in neural cell proliferation and survival. Participates as well in bone homeostasis and inhibits osteoclast differentiation by preventing NF-kappa-B nuclear translocation and activation. Mechanistically, exerts its biological effects through a receptor composed of IL3RA subunit and a signal transducing subunit IL3RB. Receptor stimulation results in the rapid activation of JAK2 kinase activity leading to STAT5-mediated transcriptional program. Alternatively, contributes to cell survival under oxidative stress in non-hematopoietic systems by activating pathways mediated by PI3K/AKT and ERK. . |
Accessions | Q6NZ78 P08700 ENST00000296870.3 Q6NZ79 |